Charmacy Pharmaceutical Co., Ltd. (2289.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 707.09M |
| Enterprise Value | 2.04B |
| P/E Ratio | 15.02 |
| PEG Ratio | -0.94 |
| Price/Sales Ratio | 0.16 |
| Price/Book Ratio | 1.1 |
| Enterprise/Revenue | 0.46 |
| Enterprise/EBITDA | 13.08 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.08 |
Income Statement
| Revenue | 4.38B |
| Revenue/Share | 40.6 |
| Gross Profit | 336.01M |
| EBITDA | 152.14M |
| Net Income | 46.27M |
| Diluted EPS | 0.43 |
Balance Sheet
| Total Cash | 753.92M |
| Total Cash/Share | 6.98 |
| Total Debt | 2.09B |
| Total Debt/Equity | 3.39 |
| Current Ratio | 1.09 |
| Book Value Per Share | 5.71 |
Price History
| 52-Week Change | 3.55 |
| 52-Week High | 7.4 |
| 52-Week Low | 4.3 |
| Moving Average 50 Days | 6.11 |
| Moving Average 200 Days | 6.12 |
Statistics
| Average Volume | 614 |
| Shares Outstanding | 108M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.3 |
| Trailing Annual Dividend Yield | 4.71 |
| Payout Ratio | 0.35 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
